| Name | 2-[4-(difluoromethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
|---|---|
| Synonyms |
1,3,2-dioxaborolane,2-[4-(difluoromethyl)phenyl]-4,4,5,5-tetramethyl
2-(4-(difluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
| Molecular Formula | C13H17BF2O2 |
|---|---|
| Molecular Weight | 254.08100 |
| Exact Mass | 254.12900 |
| PSA | 18.46000 |
| LogP | 2.92340 |
| HS Code | 2934999090 |
|---|
|
~38%
1234319-14-2 |
| Literature: Pfizer Inc. Patent: US2012/214791 A1, 2012 ; Location in patent: Page/Page column 27 ; US 20120214791 A1 |
|
~%
1234319-14-2 |
| Literature: Pfizer Inc. Patent: US2012/214791 A1, 2012 ; US 20120214791 A1 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |